Brazil Establishes Clinical Trial Review Times

Drug Industry Daily
A A
Brazil’s Anvisa has set a 90-day timeline for reviewing requests to conduct clinical trials that are also being done in other countries.

To View This Article:

Login

Subscribe To Drug Industry Daily